The SCNN1A gene helps make a channel that lets sodium move into cells, especially in the kidneys, lungs, colon, and sweat glands. This gene helps your body keep the right balance of salt and water. If it does not work well, some people can lose too much salt and become dehydrated, with low blood pressure, high potassium, or poor growth, often starting in infancy. A few variants can make the channel too active, which may raise blood pressure.
What is a gene?
Genes are stretches of DNA that carry instructions cells use to make molecules or regulate activities in the body. Some genes provide the code for proteins, which do much of the cell’s work. Others are used mainly to manage when, where, and how strongly certain body processes take place. In combination, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medicines. More detail on this topic is available in the LearnHub.
Overview
SCNN1AGene function
What if the gene works
The SCNN1A gene helps form a channel that moves sodium into certain cells. This supports salt and water balance in the kidneys, lungs, and other tissues, and helps regulate blood pressure and the moisture lining the airways.
Risk
What if the gene does not work
More disruptive variants in the SCNN1A gene can cause a condition where the body loses too much salt, often starting in infancy, with dehydration, low blood pressure, and high potassium. Milder variants may lead to a wider range of symptoms and severity.
Treatment
What does that mean for your treatment
For people with loss-of-function variants in the SCNN1A gene, treatment usually centers on ongoing salt replacement and careful control of high potassium, often using sodium bicarbonate or potassium binding medicines. Medicines that raise aldosterone signaling, such as fludrocortisone, often offer limited benefit because the affected sodium channel does not respond well. No SCNN1A targeted drug is currently established.
Conditions associated with SCNN1A
Gene function
What if the gene works
Your body uses the SCNN1A gene to manage salt and water in everyday tissues such as the kidneys, lungs, and glands. It provides one key part of a sodium channel, a tiny doorway that lets sodium move into certain surface lining cells. This is a central part of how the SCNN1A gene helps control salt and water balance in the body.
The SCNN1A gene provides the alpha part of an epithelial sodium channel, which lets sodium move into certain cells. These channels are found in tissues such as kidney tubules, airways, the colon, and some glands.
When sodium moves through this channel, water can follow in a controlled way. That helps keep surface fluids at useful levels and supports smooth day to day tissue function.
In the kidneys, this channel helps reclaim small amounts of sodium from forming urine back into the body. This steady step supports normal blood volume and helps regulate overall salt balance.
In sweat and salivary glands, the channel helps draw sodium back from fluid as it passes through ducts. This helps the body fine tune how much salt is kept in everyday secretions.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many have no noticeable effect and are simply part of natural genetic variation. In some situations, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SCNN1A gene can change the shape, stability, or cell surface delivery of the alpha part of a sodium channel, so the channel moves less sodium across the cell membrane. In descriptions of SCNN1A gene variant effects, this usually means reduced channel activity rather than a complete shutdown. Milder variants may leave some function, while more severe variants can greatly reduce or abolish it, which often lines up with earlier or more marked features of systemic pseudohypoaldosteronism type 1.
How variants are linked to conditions
Pathogenic variants in the SCNN1A gene are a well-established cause of systemic pseudohypoaldosteronism type 1, a rare inherited condition that can lead to salt loss, dehydration, low blood pressure, and high potassium, often starting in infancy. In discussions of conditions linked to the SCNN1A gene, this is the main diagnosis with broad clinical agreement. Different variants can affect severity, but a confirmed disease-causing SCNN1A variant can establish the diagnosis in the right clinical setting.
A variant is not necessarily a diagnosis
Variants in genes are a routine part of human biology and are widely present in the general population. Most do not have a direct effect on health and instead represent normal human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definitive diagnosis, especially when multiple genes and environmental factors also contribute. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SCNN1A, risk is usually driven mainly by whether you inherited a disease-causing gene change. Symptoms can become more likely or more severe during dehydration, heavy sweating, vomiting, or diarrhea, and in some families a high-salt diet can make high blood pressure worse.
Inheritance of SCNN1A variants
SCNN1A-related pseudohypoaldosteronism type 1 is inherited in an autosomal recessive pattern. This means a child usually inherits one SCNN1A gene variant from each parent. Parents who each carry one variant are often unaffected, and with each pregnancy there is a 25% chance the child will inherit both altered copies, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither variant. This SCNN1A gene inheritance pattern affects boys and girls equally.
What does my SCNN1A result mean for my family?
For SCNN1A, family meaning is usually discussed in the setting of a recessive salt-balance condition. This often means parents are healthy carriers, and brothers or sisters may also be affected or may be carriers. Other close relatives on both sides of the family could be carriers too, especially if there is a history of similar symptoms in infancy.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the SCNN1A gene, SCNN1A genetic testing uses a blood or saliva sample to read the gene’s DNA code. A lab looks for changes linked to inherited salt balance conditions and reports whether a variant is found, which may help clarify a diagnosis or carrier status.
When should I consider getting a genetic test?
Genetic testing for the SCNN1A gene may be worth considering when a baby or child has severe salt loss, dehydration, high potassium, or repeated chest symptoms that suggest a rare inherited salt-balance condition called pseudohypoaldosteronism type 1. It can also help if this condition runs in the family or both parents are known carriers.
A genetic result is only one part of your health story
A genetic result can provide useful insight, although what it shows depends on the condition and the kind of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people can take the same treatment and have different results because their bodies may absorb, process, or respond to the drug in different ways. These inherited differences are common and can influence how well a medicine works or how sensitive someone is to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect their response to medications. It focuses on the relationship between genes and drugs to help explain why the same treatment may work differently in different people. For many medicines, genes can influence how strongly a drug works or how the body handles it. This information can support treatment decisions that are better informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the SCNN1A gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so medication concerns are best discussed with your doctor. Seek medical advice if you have side effects, your treatment is not working as expected, or you are starting a new medicine for blood pressure, breathing, or salt-balance problems.
History
The SCNN1A gene entered medical genetics through research on salt handling in the kidney and other tissues during the late 20th century. In the 1990s, researchers identified SCNN1A as one of the genes encoding parts of the epithelial sodium channel, a milestone that helped connect basic laboratory findings with inherited salt balance conditions. Building on this early work, scientists linked variants in the SCNN1A gene to some forms of pseudohypoaldosteronism type 1, a condition in which the body has trouble holding on to salt. These discoveries helped clarify why some newborns and children developed dehydration, low sodium levels, and poor weight gain despite normal care. Over time, descriptions became more precise as genetic testing made it easier to confirm the cause in affected families.